Evidence map›Paper›PMID 24285988›Full record

ArticleThe open orthopaedics journal2013

In vitro elution characteristics of gentamicin and vancomycin from synthetic bone graft substitutes.

Gerrit Steffen Maier, Klaus Edgar Roth, Stefan Andereya, Klaus Birnbaum, Christopher Niedhart, Markus Lühmann, Jörg Ohnsorge, Uwe Maus

Open access · hybridAbstract read
In one paragraph

Article in The open orthopaedics journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Gerrit Steffen MaierDepartment of Orthopedic Surgery, Johannes-Guttenberg-University, Langenbeckstrasse 1, D-55131 Mainz, Germany.
Klaus Edgar Roth
Stefan Andereya
Klaus Birnbaum
Christopher Niedhart
Markus Lühmann
Jörg Ohnsorge
Uwe Maus
Johannes Gutenberg University Mainz · DEOrthopädische Praxis · DEPius Hospital Oldenburg · DEPraxis für Humangenetik · DESt.-Antonius-Hospital Gronau · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectsBeta tricalciumphosphate pellets loaded with individualized antibiotics may represent novel options in the treatment of osteomyelitis and infectious bone disease. Here, the in vitro antibiotic elution of vancomycin and gentamicin from the synthetic bone graft substitutes Cerasorb(®) and Cerasorb M(®) was tested.

methodsAntibiotic elution and concentration of gentamcin and vancomycin were measured using photometrically-based measurement and homogeneous particle-enhanced turbidimetric inhibition immunoassays (PETINIA).

resultsInitially both materials showed a high release of the loaded antibiotics, with Cerasorb M(®) showing lower release levels for gentamicin and vancomycin than Cerasorb(®). Gentamicin concentrations of Cerasorb M granules and Cerasorb were below the minimum detectiontreshold until day four and six of the experiment respectively. The vancomycin release-level followed a similar pattern, although the vancomycin concentration eluted by Cerasorb M(®) granules stayed above the detection threshold during the experimental time.

conclusionsCerasorb(®) and Cersorb M(®) may represent a new treatment option in osteomyelitis and infectious bone disease.

Indexed as

beta tricalciumphosphate.Cerasorb®Cerasorb M®Osteomyelitis

Identifiers

PMID24285988
PMCPMC3841967
OpenAlexW2170163048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.